drugset / Trial / NCT00510107
Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of weekly administered combination of docetaxel/cisplatin and docetaxel/oxaliplatin in chemotherapy-naïve patients with advanced gastric cancer. The primary endpoint will be the response rate.
Timeline
- Start
- 2007-07
- Primary completion
- —
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cisplatin | Other / unclassified | 60 mg/m2 | — |
| Subject | Oxaliplatin | Small molecule | 120 mg/m2 | — |